Profile
Full Name
Outlook Therapeutics, Inc.Ticker Symbol
OTLKExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
June 14, 2016Indexes
Not includedEmployees
23Key Details
Price
$1.36(-2.16%)
Market cap
$43.54M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$4.06(+13.98% YoY)
PE ratio
-
Next earnings date
May 16, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Outlook Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Feb 24, 25 Ascendiant Capital
BuyFeb 18, 25 HC Wainwright & Co.
BuyFeb 18, 25 Chardan Capital
NeutralJan 17, 25 HC Wainwright & Co.
BuyJan 17, 25 Guggenheim
BuyDec 2, 24 Chardan Capital
NeutralNov 29, 24 HC Wainwright & Co.
BuyNov 29, 24 BTIG
BuyAug 16, 24 Chardan Capital
BuyAug 15, 24 HC Wainwright & Co.
BuyInstitutional Ownership
- What is the ticker symbol for Outlook Therapeutics?
- Does Outlook Therapeutics pay dividends?
- What sector is Outlook Therapeutics in?
- What industry is Outlook Therapeutics in?
- What country is Outlook Therapeutics based in?
- When did Outlook Therapeutics go public?
- Is Outlook Therapeutics in the S&P 500?
- Is Outlook Therapeutics in the NASDAQ 100?
- Is Outlook Therapeutics in the Dow Jones?
- When was Outlook Therapeutics's last earnings report?
- When does Outlook Therapeutics report earnings?
- Should I buy Outlook Therapeutics stock now?
What is the ticker symbol for Outlook Therapeutics?
The ticker symbol for Outlook Therapeutics is NASDAQ:OTLK
Does Outlook Therapeutics pay dividends?
No, Outlook Therapeutics does not pay dividends
What sector is Outlook Therapeutics in?
Outlook Therapeutics is in the Healthcare sector
What industry is Outlook Therapeutics in?
Outlook Therapeutics is in the Biotechnology industry
What country is Outlook Therapeutics based in?
Outlook Therapeutics is headquartered in United States
When did Outlook Therapeutics go public?
Outlook Therapeutics's initial public offering (IPO) was on June 14, 2016
Is Outlook Therapeutics in the S&P 500?
No, Outlook Therapeutics is not included in the S&P 500 index
Is Outlook Therapeutics in the NASDAQ 100?
No, Outlook Therapeutics is not included in the NASDAQ 100 index
Is Outlook Therapeutics in the Dow Jones?
No, Outlook Therapeutics is not included in the Dow Jones index
When was Outlook Therapeutics's last earnings report?
Outlook Therapeutics's most recent earnings report was on Feb 14, 2025
When does Outlook Therapeutics report earnings?
The next expected earnings date for Outlook Therapeutics is May 16, 2025
Should I buy Outlook Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions